Biography
Dr. Cheryl Ewing is Associate Professor of Surgery at UCSF Mount Zion Hospital. Her focus is in breast cancer surgery and sentinel lymph node dissection. Her other interests include quality of care and evaluation of barriers to medical and breast care for minority women.
Dr. Ewing completed her undergraduate education at the University of Michigan, and received her medical degree from Wayne State University School of Medicine. She then went on to complete her residency at University of Michigan Medical School, and then her fellowship at the University of Chicago. She joined the faculty at UCSF in 2001.
Dr. Ewing has lectured extensively at many local, national, and international events. She has been very active in mentoring residents and fellows, serving four years as the Mount Zion Site Director for the Surgery 110 Rotations and teaching several CME courses and Grand Rounds.
Dr. Ewing is involved in several studies involving quality of care among breast cancer survivors. Specifically, these involve post-surgery symptom management, and customizing risk assessment and tailoring treatment to the individual patient's medical profile and preferences. Her primary focus in on how being a breast cancer survivor affects the quality of life in different race/ethnic groups, and how that relationship is modified by social support, depression, and spirituality.
Dr. Ewing is a member of most of the major surgical societies, and has been the recipient of several awards, including the Susan G. Komen Local Hero Award.
Dr. Ewing completed her undergraduate education at the University of Michigan, and received her medical degree from Wayne State University School of Medicine. She then went on to complete her residency at University of Michigan Medical School, and then her fellowship at the University of Chicago. She joined the faculty at UCSF in 2001.
Dr. Ewing has lectured extensively at many local, national, and international events. She has been very active in mentoring residents and fellows, serving four years as the Mount Zion Site Director for the Surgery 110 Rotations and teaching several CME courses and Grand Rounds.
Dr. Ewing is involved in several studies involving quality of care among breast cancer survivors. Specifically, these involve post-surgery symptom management, and customizing risk assessment and tailoring treatment to the individual patient's medical profile and preferences. Her primary focus in on how being a breast cancer survivor affects the quality of life in different race/ethnic groups, and how that relationship is modified by social support, depression, and spirituality.
Dr. Ewing is a member of most of the major surgical societies, and has been the recipient of several awards, including the Susan G. Komen Local Hero Award.
Education
Education
- 1978-83, Wayne State University School of Medicine, MD
Residencies
- 1983-88, St. Joseph Mercy Hospital, University of Michigan Medical School
Board Certifications
- 1984, American Board of Surgery
- 1998, American Board of Surgery
Program Affiliations
- UCSF Helen Diller Family Comprehensive Cancer Center
Research Interests
- Mastectomy
- Sentinel Lymph Node Biopsy
- Ductal Carcinoma In Situ (DCIS)
- Minority Health
Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 61
- Balancing risks of surgical complications and positive margins for patients with invasive lobular carcinoma of the breast and elevated BMI: An institutional cohort study.| | PubMed
- Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy.| | PubMed
- Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.| | PubMed
- Area Deprivation Index in Patients with Invasive Lobular Carcinoma of the Breast: Associations with Tumor Characteristics and Outcomes.| | PubMed
- Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic Therapy.| | PubMed
- Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial.| | PubMed
- Breast Conservation Surgery and Mastectomy Have Similar Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From 1462 Patients on the Prospective, Randomized I-SPY2 Trial.| | PubMed
- Expanding Candidacy for Nipple-sparing Mastectomy in Women with Large or Ptotic Breasts: Staged Reconstruction Outcomes.| | PubMed
- Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial.| | PubMed
- Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial.| | PubMed